Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SCPH scPharmaceuticals Inc
- Stocks
- Healthcare
- NASDAQ: SCPH
Price (delayed)
$3.22
Market cap
$169.99M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.87
Enterprise value
$192.48M
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships,
Highlights
The revenue has surged by 138% year-on-year and by 16% since the previous quarter
scPharmaceuticals's gross profit has surged by 129% YoY and by 16% QoQ
The company's EPS fell by 26% YoY but it rose by 2.1% QoQ
The equity has plunged by 138% from the previous quarter and by 121% YoY
SCPH's debt has soared by 96% YoY
Key stats
What are the main financial stats of SCPH
Market
Valuations
Earnings
Shares outstanding
52.79M
Market cap
$169.99M
Enterprise value
$192.48M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
4.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.58
Revenue
$41.98M
Gross profit
$28.94M
Operating income
-$66.68M
Net income
-$90.78M
EBIT
-$83.93M
EBITDA
-$83.77M
Free cash flow
-$70M
Per share
Balance sheet
Liquidity
EPS
-$1.87
EPS diluted
-$1.87
Free cash flow per share
-$1.3
Book value per share
-$0.1
Revenue per share
$0.78
TBVPS
$1.69
Total assets
$90.96M
Total liabilities
$96.09M
Debt
$80.03M
Equity
-$5.13M
Working capital
$73.04M
Debt to equity
-15.61
Current ratio
5.48
Quick ratio
4.38
Net debt/EBITDA
-0.27
Margins
Efficiency
Dividend
EBITDA margin
-199.5%
Gross margin
68.9%
Net margin
-216.2%
Operating margin
-158.8%
Return on assets
-93.3%
Return on equity
-754.1%
Return on invested capital
-96.8%
Return on capital employed
-112.4%
Return on sales
-199.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SCPH stock price
How has the scPharmaceuticals stock price performed over time
Intraday
11.81%
1 week
31.97%
1 month
26.27%
1 year
-33.33%
YTD
-9.04%
QTD
22.43%
Financial performance
How have scPharmaceuticals's revenue and profit performed over time
Revenue
$41.98M
Gross profit
$28.94M
Operating income
-$66.68M
Net income
-$90.78M
Gross margin
68.9%
Net margin
-216.2%
The revenue has surged by 138% year-on-year and by 16% since the previous quarter
scPharmaceuticals's gross profit has surged by 129% YoY and by 16% QoQ
scPharmaceuticals's net income has shrunk by 57% YoY and by 7% QoQ
scPharmaceuticals's operating margin has soared by 53% YoY and by 11% from the previous quarter
Price vs fundamentals
How does SCPH's price correlate with its fundamentals
Growth
What is scPharmaceuticals's growth rate over time
Valuation
What is scPharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
4.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.58
The company's EPS fell by 26% YoY but it rose by 2.1% QoQ
The equity has plunged by 138% from the previous quarter and by 121% YoY
The revenue has surged by 138% year-on-year and by 16% since the previous quarter
SCPH's price to sales (P/S) is 24% lower than its last 4 quarters average of 5.4
Efficiency
How efficient is scPharmaceuticals business performance
SCPH's ROE has dropped by 72% since the previous quarter
The return on assets has dropped by 59% year-on-year and by 3.1% since the previous quarter
scPharmaceuticals's return on invested capital has decreased by 46% YoY but it has increased by 7% QoQ
The company's return on sales rose by 29% YoY and by 6% QoQ
Dividends
What is SCPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SCPH.
Financial health
How did scPharmaceuticals financials performed over time
The company's total assets is 5% lower than its total liabilities
scPharmaceuticals's total liabilities has soared by 78% YoY and by 2% from the previous quarter
The company's quick ratio fell by 25% QoQ and by 16% YoY
The equity has plunged by 138% from the previous quarter and by 121% YoY
SCPH's debt has soared by 96% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.